Tag Archives: NYSE:MRT

MedEquities Realty Trust Receives a Buy from Cantor Fitzgerald

Cantor Fitzgerald analyst Joseph France maintained a Buy rating on MedEquities Realty Trust (NYSE: MRT) today and set a price target of $14. The company’s shares closed yesterday at $10.75. France wrote: “MRT reported in-line 4Q17 results and issued 2018

MedEquities Realty Trust Received its Third Buy in a Row

After KeyBanc and B.Riley FBR assigned a Buy rating to MedEquities Realty Trust in the last month, the company received another Buy, this time from Cantor Fitzgerald. Analyst Joseph France reiterated a Buy rating on MedEquities Realty Trust (NYSE: MRT)

MedEquities Realty Trust Initiated with a Buy at Cantor Fitzgerald

Cantor Fitzgerald analyst Joseph France initiated coverage with a Buy rating on MedEquities Realty Trust (NYSE: MRT) today and set a price target of $14. The company’s shares opened today at $11.46. France noted: “Post-acute care focus. MRT is focused

KeyBanc Keeps a Buy Rating on MedEquities Realty Trust

KeyBanc analyst Jordan Sadler reiterated a Buy rating on MedEquities Realty Trust (NYSE: MRT) yesterday and set a price target of $13. The company’s shares closed yesterday at $11.40. According to TipRanks.com, Sadler is a 4-star analyst with an average

MedEquities Realty Trust Receives a Buy from FBR Capital

FBR Capital analyst Bryan Maher reiterated a Buy rating on MedEquities Realty Trust (NYSE: MRT) on November 8. The company’s shares closed yesterday at $11.19. According to TipRanks.com, Maher is a 1-star analyst with an average return of -3.2% and